Alembic Pharmaceuticals Ltd receives EIR for its new Injectable Facility (F-3) at Karakhadi

Alembic Pharmaceuticals Ltd has received Establishment Inspection Report (EIR) from US Food and Drug Administration (USFDA) for the inspection carried out by them at our New Injectable Facility (F-3) at Karakhadi during the period from 28th January, 2021 to 6th February, 2021, indicating that the USFDA finds our responses to their observations to be adequate. USFDA has also indicated that a compliance verification would be performed during re-inspection of the said Facility in the next review cycle.

Shares of Alembic Pharmaceuticals Limited was last trading in BSE at Rs. 777.35 as compared to the previous close of Rs. 777.80. The total number of shares traded during the day was 3924 in over 342 trades.

The stock hit an intraday high of Rs. 784.85 and intraday low of 776.05. The net turnover during the day was Rs. 3065439.00.

Shares of Alembic Pharmaceuticals Limited was last trading in NSE at Rs. 777.00 as compared to the previous close of Rs. 777.90. The total number of shares traded during the day was 117586 in over 5138 trades.

The stock hit an intraday high of Rs. 785.00 and intraday low of 776.00. The total traded value during the day was Rs. 91737893.50.

Source : Equity Bulls

Keywords

AlembicPharmaceuticals INE901L01018 APL Pharmaceuticals